Clear Cell Renal Cell Carcinoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Completed
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • pazopanib hydrochloride
  • +2 more
  • Duarte, California
  • +1 more
2022-04-01
Apr 1, 2022
O
Recruiting
  • Melanoma Stage IV
  • +4 more
  • Fecal Microbiota Transplant (FMT)
  • Oslo, Norway
    Oslo University Hospital
2022-03-31
Mar 31, 2022
A
Terminated
  • Clear Cell Renal Cell Carcinoma
  • +4 more
  • Ascorbic Acid
  • Pazopanib Hydrochloride
  • Peoria, Illinois
  • +4 more
2022-03-18
Mar 18, 2022
N
Recruiting
  • Advanced Renal Cell Carcinoma
  • +8 more
  • Cabozantinib S-malate
  • +3 more
  • Birmingham, Alabama
  • +33 more
2022-03-25
Mar 25, 2022
D
Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Boston, Massachusetts
  • +1 more
2022-03-21
Mar 21, 2022
B
Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Nivolumab and rHuPH20
  • Nivolumab
  • Chicago, Illinois
  • +104 more
2022-03-15
Mar 15, 2022
N
Recruiting
  • ccRCC
  • +9 more
  • Oral NKT2152
  • Scottsdale, Arizona
  • +5 more
2022-03-09
Mar 9, 2022
Q
Recruiting
  • Clear Cell Renal Cell Carcinoma
  • No intervention was required for patients or control group in this study
  • Jinan, China
    The First Affiliated Hospital of Shandong First Medical Universi
2022-03-07
Mar 7, 2022
R
Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Stage IV Renal Cell Cancer
  • Bevacizumab
  • +3 more
  • Westwood, Kansas
  • +4 more
2022-03-03
Mar 3, 2022
M
Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Cryosurgery
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-14
Feb 14, 2022
N
Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +6 more
  • Orange, California
  • +28 more
2022-03-01
Mar 1, 2022
M
Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-25
Feb 25, 2022
M
Active, not recruiting
  • Bladder Urothelial Carcinoma
  • +4 more
  • Biopsy
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-25
Feb 25, 2022
A
Not yet recruiting
  • Clear Cell Renal Cell Carcinoma
  • First-line Treatment
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
2022-02-16
Feb 16, 2022
A
Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Boston, Massachusetts
  • +9 more
2022-02-21
Feb 21, 2022
E
Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
2022-02-18
Feb 18, 2022
M
Recruiting
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
2022-02-16
Feb 16, 2022
A
Active, not recruiting
  • Advanced Kidney Cancer
  • +2 more
  • Chicago, Illinois
  • +4 more
2022-02-16
Feb 16, 2022
M
Terminated
  • Mesothelioma
  • +12 more
  • MGD009
  • Los Angeles, California
  • +19 more
2022-02-04
Feb 4, 2022
N
Completed
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Birmingham, Alabama
  • +986 more
2022-01-13
Jan 13, 2022
S
Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Duarte, California
  • +22 more
2022-01-20
Jan 20, 2022
N
Completed
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Rochester, Minnesota
  • +1 more
2022-01-12
Jan 12, 2022